Home > Reading Room > Johnson and Johnson Patent Lawsuit Settled

Johnson and Johnson Patent Lawsuit Settled

Written by Jane Coyle on 19 September 2007

« Return to Reading Room

Angiotech Pharmaceuticals, Inc said it has reached a 'favourable' agreement with Johnson & Johnson's subsidiary, Conor Medsystems to settle all outstanding patent litigation over Conor's CoStar paclitaxel stent: terms of the settlement were not disclosed. 'With this agreement now in place, Angiotech expects that the resources required to defend and enforce our intellectual property should decrease,' said Dr. William Hunter, CEO of Angiotech.

At the time of the settlement, there was ongoing litigation in three jurisdictions: the UK, the Netherlands and Australia.

If you'd like to know more about this article please send an email to Unknown quoting the article title and any questions you might have, alternatively call the office number on 02380 235 979 or send an enquiry through our contact form.

Want to speak
to someone?

Complete the form below and we’ll call you back free of charge.

Visual Captcha